Table 1 Characteristics of all unique pilot study participants
Variable | All participants (n = 226) | Control (n = 117) | Intervention (n = 109) |
|---|---|---|---|
Age (years), mean (SD) | 62 (15) | 61 (16) | 63 (12) |
Sex | |||
 • Males, n (%) | 156 (69) | 76 (65) | 80 (73) |
 • Females, n (%) | 70 (31) | 41(35) | 29 (27) |
Ethnicity, n (%) | |||
 • White European | 177 (78) | 81 (69) | 96 (88) |
 • Indigenous | 14 (6) | 6 (5) | 8 (7) |
 • Other | 35 (16) | 30 (26) | 5 (5) |
Co-morbiditiesa, n (%) | |||
 • Diabetes mellitus | 111 (49) | 56 (48) | 57 (52) |
 • Ischemic heart disease | 74 (33) | 41 (35) | 33 (30) |
 • Cerebrovascular disease | 26 (12) | 15 (13) | 11 (10) |
 • Peripheral vascular disease | 47 (21) | 25 (21) | 22 (20) |
 • Chronic lung disease | 42 (19) | 22 (19) | 20 (18) |
Primary kidney disease, n (%) | |||
 • Diabetic Nephropathy | 73 (32) | 38 (32) | 35 (32) |
 • Glomerulonephritis | 53 (24) | 23 (20) | 30 (28) |
 • Hypertension | 27 (12) | 16 (14) | 11 (10) |
 • Other | 73 (32) | 40 (34) | 33 (30) |
Years on hemodialysis, median (IQR) | 1.62 (0.62, 2.87) | 1.56 (0.45, 3.14) | 1.71 (0.93, 2.87) |